Astrazeneca takes Bicycle to work in potential $1B multitarget collaboration
LONDON – Bicycle Therapeutics Ltd. has convinced Astrazeneca plc of the attractions of its novel peptide platform, signing up the pharma in a potential $1 billion discovery and development collaboration in respiratory, cardiovascular and metabolic disorders.
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST